TFT 5 mark answer

Asking for Preferences

Thyroid function test 5 mark answer

Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have excellent, comprehensive content from authoritative textbooks. Let me compile the full 5-mark answer.

Thyroid Function Tests (TFTs)

Definition & Overview

Thyroid function tests (TFTs) are a panel of blood tests used to assess the functional status of the thyroid gland. They measure the levels of thyroid hormones and pituitary TSH to diagnose and monitor thyroid disorders.

Hormones Measured

The thyroid gland produces two major hormones of clinical interest:
  1. Thyroxine (T4) - a prohormone; most circulating T4 is converted peripherally to T3
  2. Triiodothyronine (T3) - the active hormone
  • Circulating T4 is slowly metabolized, mostly to T3, and a smaller amount is converted to the inactive metabolite reverse T3 (rT3).
  • T4 and T3 are highly protein-bound in serum (primarily to thyroid-binding globulin [TBG] and prealbumin/transthyretin).
  • Only ~0.02% of T4 and ~0.2% of T3 circulate as free, biologically active hormones.

Tests in the Panel

1. Thyroid-Stimulating Hormone (TSH / Thyrotropin)

  • A pituitary hormone that stimulates production and release of thyroid hormones.
  • Through a tightly regulated negative feedback loop, TSH rises when T3/T4 fall, and falls when T3/T4 rise.
  • Small changes in free T3 and T4 produce large changes in TSH, making it the most sensitive indicator.
  • Normal range: 0.3 - 3.3 mU/L.
  • TSH is the best first-line test for thyroid function. A normal TSH essentially excludes thyroid dysfunction.
  • Measured by immunochemiluminometric assay (can detect very low levels).

2. Free T4 (fT4)

  • Measured when TSH is abnormal.
  • Normal range: 10-30 nmol/L.
  • Not affected by TBG fluctuations (unlike total T4).
  • Elevated in hyperthyroidism; low in hypothyroidism.

3. Free T3 (fT3)

  • Measured in select circumstances: to diagnose T3 toxicosis, investigate analytical interference with fT4 assay, assess impaired T4-to-T3 conversion, or monitor patients on oral T3 therapy.
  • Normal range: 3.5-7.5 µmol/L.

4. Thyroid Autoantibodies (supplementary)

  • Anti-thyroid peroxidase (TPO) antibody and anti-thyroglobulin antibody - useful for determining the cause of thyroid dysfunction (e.g., Hashimoto's thyroiditis).
  • TSH receptor antibodies (TRAb/TSI) - present in Graves' disease.

Interpretation of TFT Patterns

ConditionTSHFree T4Free T3
Euthyroid (normal)NormalNormalNormal
Primary hypothyroidism↑ High↓ Low↓ Low
Primary hyperthyroidism (thyrotoxicosis)↓ Undetectable↑ High↑ High
T3 toxicosis↓ Low/undetectableNormal↑ High
Subclinical hypothyroidism↑ HighNormalNormal
Subclinical hyperthyroidism↓ LowNormalNormal
Euthyroid sick syndrome (NTI)Normal to ↓↓ (↑ rT3)

Factors Affecting TBG (and hence Total T3/T4)

TBG Increased (raises total T4/T3)TBG Decreased (lowers total T4/T3)
PregnancyHypoproteinemia (nephrotic syndrome, liver disease)
Oral contraceptives / estrogen therapyAndrogen therapy
Active hepatitisGlucocorticoids / cortisol
Hypothyroidism
This is why free hormone levels (fT4, fT3) are preferred over total hormone levels for accurate assessment.

Testing Strategy

  1. Start with TSH - best initial screening test.
  2. If TSH is abnormal, add free T4.
  3. Add free T3 only in select situations (T3 toxicosis, monitoring T3 therapy).

When NOT to Rely on TSH Alone:

  • Critically ill patients (euthyroid sick syndrome): low T4, T3, and normal-to-low TSH without true thyroid disease.
  • Early thyroid replacement therapy: TSH may remain abnormally low for a prolonged period due to long-term thyrotroph cell suppression.
  • Pituitary/hypothalamic disease (secondary hypothyroidism): TSH may be inappropriately low/normal despite low T4.

Radioactive Iodine Uptake (RAIU) - Additional Test

A nuclear medicine test where the patient is given radioactive iodine and the thyroid is scanned:
  • Increased RAIU: Graves' disease, functioning adenoma.
  • Decreased RAIU: Thyroiditis, struma ovarii, exogenous thyroid hormone ingestion.

Sources: Quick Compendium of Clinical Pathology 5th edition, p. 39 | Bailey and Love's Short Practice of Surgery 28th Edition, p. 874
This is a shared conversation. Sign in to Orris to start your own chat.